Bioxyne Limited
ASX: BXN.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- CEO
- Samuel Watson
- Employees
- 16
- Headquarters
- Sydney, Australia
- IPO year
- 2000
- Market cap
- A$158.9M
- Website
- https://www.bioxyne.com
Loading BXN…
Loading profile data…Frequently asked questions about BXN
What does Bioxyne Limited (BXN.AX) do?
Bioxyne Limited, a life sciences and health products company, researches, develops, markets, and distributes dietary supplement and beauty products. It perates in two segments, Wholesale Sales and Direct Sales. The company engages in developing various functional foods and beauty products. Its products portfolio includes Progastrim for Gut and I...
Where does BXN.AX trade?
Bioxyne Limited (BXN.AX) trades on the Australian Securities Exchange.
What sector is BXN.AX in?
Bioxyne Limited (BXN.AX) operates in the Consumer Defensive sector, specifically in the Packaged Foods industry.
Who is the CEO of Bioxyne Limited?
Samuel Watson is the chief executive officer of Bioxyne Limited (BXN.AX).
Where is Bioxyne Limited headquartered?
Bioxyne Limited is headquartered in Australia.
Does BXN.AX pay a dividend?
Bioxyne Limited (BXN.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BXN.AX go public?
Bioxyne Limited (BXN.AX) completed its initial public offering in 2000.